ALTERATION IN EXPRESSION OF SERRATIA-MARCESCENS PORINS ASSOCIATED WITH DECREASED OUTER-MEMBRANE PERMEABILITY

被引:11
作者
HASHIZUME, T
SANADA, M
NAKAGAWA, S
TANAKA, N
机构
[1] Tsukuba Research Institute, Banyu Pharmaceutical Co., Tsukuba 300-33
关键词
D O I
10.1093/jac/31.1.21
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The porin expression of two clinical isolates of Serratia marcescens, which overproduced cephalosporinase and had decreased outer membrane permeability, were studied in comparison with those of reference strains. Separation of the porin proteins assessed by SDS-PAGE containing urea revealed that both clinical isolates overexpressed a single porin of 44 and 43 kilodalton (kDa), respectively. In contrast, the in-vitro porin deficient mutant, which was derived from the reference strain IF03736 as latamoxef-resistant, showed decreased outer membrane permeability, but produced low levels of all three peptidoglycan associated porins of 45, 44 and 43 kDa, and overexpressed 39 kDa OmpA protein. These observations suggested that the clinical isolates had a different mechanism of latamoxef resistance compared with the mutant and overexpressed possible narrow transport channels of 44 or 43 kDa. The 45 kDa porin may facilitate a more effective channel than the other two proteins. Heterogeneity of porin profiles between biotypes was also suggested. The two isolates were also resistant to penicillins and cephalosporins tested, but imipenem was the most active agent and inhibited the isolates at 1.56 mg/L. © 1993 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 13 条
[1]  
GRIMONT PAD, 1978, J CLIN MICROBIOL, V8, P73
[2]   DIFFERENT MECHANISMS OF RESISTANCE TO LATAMOXEF (MOXALACTAM) IN SERRATIA-MARCESCENS [J].
GUTMANN, L ;
CHABBERT, YA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (01) :15-22
[3]   CROSS-RESISTANCE TO NALIDIXIC-ACID, TRIMETHOPRIM, AND CHLORAMPHENICOL ASSOCIATED WITH ALTERATIONS IN OUTER-MEMBRANE PROTEINS OF KLEBSIELLA, ENTEROBACTER, AND SERRATIA [J].
GUTMANN, L ;
WILLIAMSON, R ;
MOREAU, N ;
KITZIS, MD ;
COLLATZ, E ;
ACAR, JF ;
GOLDSTEIN, FW .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :501-507
[4]  
HECHLER U, 1989, J GEN MICROBIOL, V135, P1275
[5]   PENETRATION OF MOXALACTAM INTO ITS TARGET PROTEINS IN ESCHERICHIA-COLI K-12 - COMPARISON OF A HIGHLY MOXALACTAM-RESISTANT MUTANT WITH ITS PARENT STRAIN [J].
KOMATSU, Y ;
MURAKAMI, K ;
NISHIKAWA, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (05) :613-619
[6]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[7]   OUTER-MEMBRANE AND PORIN CHARACTERISTICS OF SERRATIA-MARCESCENS GROWN-INVITRO AND IN RAT INTRAPERITONEAL DIFFUSION-CHAMBERS [J].
MALOUIN, F ;
CAMPBELL, GD ;
HALPENNY, M ;
BECKER, GW ;
PARR, TR .
INFECTION AND IMMUNITY, 1990, 58 (05) :1247-1253
[8]   CONTRIBUTION OF BETA-LACTAMASE HYDROLYSIS AND OUTER-MEMBRANE PERMEABILITY TO CEFTRIAXONE RESISTANCE IN ENTEROBACTER-CLOACAE [J].
MARCHOU, B ;
BELLIDO, F ;
CHARNAS, R ;
LUCAIN, C ;
PECHERE, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (10) :1589-1595
[9]   METHOD FOR MEASURING OUTER MEMBRANE-PERMEABILITY OF BETA-LACTAM ANTIBIOTICS IN GRAM-NEGATIVE BACTERIA [J].
SAWAI, T ;
MATSUBA, K ;
YAMAGISHI, S .
JOURNAL OF ANTIBIOTICS, 1977, 30 (12) :1134-1136
[10]   OUTER-MEMBRANE PERMEATION OF BETA-LACTAM ANTIBIOTICS IN ESCHERICHIA-COLI, PROTEUS-MIRABILIS, AND ENTEROBACTER-CLOACAE [J].
SAWAI, T ;
HIRUMA, R ;
KAWANA, N ;
KANEKO, M ;
TANIYASU, F ;
INAMI, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (04) :585-592